10:17:00 EDT Sat 01 Oct 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Tilray Brands Inc
Symbol TLRY
Shares Issued 481,001,074
Close 2022-08-16 C$ 5.39
Recent Sedar Documents

Tilray division receives market approval in Poland

2022-08-17 09:13 ET - News Release

Ms. Denise Faltischek reports

TILRAY MEDICAL BOLSTERS MARKET LEADING POSITION IN EUROPE WITH MARKET AUTHORIZATION IN POLAND

Tilray Brands Inc.'s medical cannabis division, Tilray Medical, has received approval to commercialize its Tilray branded medical cannabis products in Poland, expanding its product offering and distribution across pharmacies in Europe.

Denise Faltischek, Tilray's chief strategy officer and head of international business, said: "I'm extremely proud of our team in Europe for once again expanding our approved authorization for Tilray Medical products across Europe. Tilray will continue to advocate for reasonable patient access to reliable and high-quality medical cannabis in Europe and countries around the world."

Tilray Medical is a leading international provider of EU-GMP-certified (good manufacturing practice) medical cannabis products in 21 countries with a comprehensive portfolio of trusted and reliable tetrahydrocannabinol and cannabidiol products, each with a unique profile of cannabinoids and terpenes, that have been selected to ensure patients can receive both the highest product quality as well as consistency when it comes to supply of their medicinal cannabis products.

In Poland, Tilray Medical has established multiple partnerships with pharmaceutical companies to distribute both Tilray branded and unbranded medical cannabis products. Patients may obtain prescriptions for medical cannabis in Poland through their preferred medical doctor.

About Tilray Medical

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first EU-GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers and governments, in 21 countries and across five continents.

About Tilray Brands Inc.

Tilray Brands is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is changing people's lives for the better -- one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and providing access to products that meet the needs of their mind, body and soul while invoking well-being. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.